Literature DB >> 2784104

Expression of cytoplasmic granules with T cell-associated serine proteinase-1 activity in Ly-2+(CD8+) T lymphocytes responding to lymphocytic choriomeningitis virus in vivo.

M D Kramer1, U Fruth, H G Simon, M M Simon.   

Abstract

Monoclonal antibodies (mAb) with specificity for the T cell-associated serine proteinase-1 of the mouse (MTSP-1) were used to study expression and storage of this enzyme in T lymphocytes during lymphocytic choriomeningitis (LCM) virus infection in vivo. Immunohistochemical analysis of splenic tissue at the peak of LCM virus-specific T cell-mediated cytolytic responses, i.e., at day 7 post infection, revealed high numbers of MTSP-1+ T lymphocytes in the interfollicular T cell-dependent area of the spleen. More than 50% of Ly-2+(CD8+) cells but only low numbers of Ly-2-(CD8-) cells, previously enriched by flow cytofluorometry, contained large amounts of cytoplasmic granules which stained both with MTSP-1-specific mAb and the esterase substrate N-alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester. These data demonstrate that in vivo generated LCM virus-induced cytolytic T lymphocytes develop cytoplasmic storage granules containing MTSP-1 and suggest that the mechanism of granule exocytosis is operative in vivo; possibly MTSP-1 is one effector molecule participating in the Ly-2+(CD8+) T lymphocyte-mediated control of virus infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784104     DOI: 10.1002/eji.1830190124

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Mechanism of killing by virus-induced cytotoxic T lymphocytes elicited in vivo.

Authors:  R M Welsh; W K Nishioka; R Antia; P L Dundon
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

2.  Lyme carditis in immunodeficient mice during experimental infection of Borrelia burgdorferi.

Authors:  G Zimmer; U E Schaible; M D Kramer; G Mall; C Museteanu; M M Simon
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

3.  Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.

Authors:  U E Schaible; S Gay; C Museteanu; M D Kramer; G Zimmer; K Eichmann; U Museteanu; M M Simon
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Massive expansion of antigen-specific CD8+ T cells during an acute virus infection.

Authors:  E A Butz; M J Bevan
Journal:  Immunity       Date:  1998-02       Impact factor: 31.745

5.  Expression of T-cell-associated serine proteinase 1 during murine Leishmania major infection correlates with susceptibility to disease.

Authors:  H Moll; C Müller; R Gillitzer; H Fuchs; M Röllinghoff; M M Simon; M D Kramer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

6.  Cutaneous leishmaniasis: co-ordinate expression of granzyme A and lymphokines by CD4+ T cells from susceptible mice.

Authors:  S Frischholz; M Röllinghoff; H Moll
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

7.  Centrosome docking at the immunological synapse is controlled by Lck signaling.

Authors:  Andy Tsun; Ihjaaz Qureshi; Jane C Stinchcombe; Misty R Jenkins; Maike de la Roche; Joanna Kleczkowska; Rose Zamoyska; Gillian M Griffiths
Journal:  J Cell Biol       Date:  2011-02-21       Impact factor: 10.539

8.  Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes.

Authors:  P J Peters; J Borst; V Oorschot; M Fukuda; O Krähenbühl; J Tschopp; J W Slot; H J Geuze
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

9.  Granzyme A-deficient mice retain potent cell-mediated cytotoxicity.

Authors:  K Ebnet; M Hausmann; F Lehmann-Grube; A Müllbacher; M Kopf; M Lamers; M M Simon
Journal:  EMBO J       Date:  1995-09-01       Impact factor: 11.598

10.  Transcription of granzyme A and B genes is differentially regulated during lymphoid ontogeny.

Authors:  K Ebnet; C N Levelt; T T Tran; K Eichmann; M M Simon
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.